Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
501
-
502
δPKC activation following OGD decreases Bad phosphorylation via PP2A activation.
Published 2013Subjects: -
503
-
504
-
505
-
506
-
507
Decrease in number of activated macrophages in demyelinated nerves subjected to 1hr ES.
Published 2014“…Note: ES results in a significant decrease in the ED-1 IF 10d post-LPC (5d post-ES; K) and 12d post-LPC (7d post-ES; N) relative to LPC only in a pattern suggestive of movement toward lateral edges and egress (arrow). …”
-
508
-
509
-
510
HEWL interacts with dissipated oleic acid micelles, and decreases oleic acid cytotoxicity
Published 2019Subjects: -
511
The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 4
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
512
Activation of mGluR5 site-specifically decreases spine density in the nucleus accumbens.
Published 2016“…<p>(A) Schematic representation of injection sites of either vehicle (open circles) or CHPG (filled circles). …”
-
513
Drugs which cluster on the 'anxiolytic' group decrease 5-HT turnover in the brain.
Published 2014“…Points represent means and error bars represent standard errors. A negative correlation is found between the decrease in serotonin turnover and the increase in time on white produced by a drug (r<sup>2</sup> = 0.5688, p = 0.0073).…”
-
514
The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 6
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
515
Eltrombopag markedly decreases levels of ROS in MOLM14 cells.
Published 2015“…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”
-
516
-
517
-
518
-
519
-
520